UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2022

Commission File Number: 001-38810

 

 

STEALTH BIOTHERAPEUTICS CORP

 

 

Stealth BioTherapeutics Corp

c/o Intertrust Corporate Services (Cayman) Limited

One Nexus Way, Camana Bay

Grand Cayman

KY1-9005 Cayman Islands

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F  ☒            Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

 

 

 

EXHIBIT INDEX

 

Exhibit

No.

    Description
99.1    Press Release – Stealth BioTherapeutics Corp Announces Completion of Merger

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    STEALTH BIOTHERAPEUTICS CORP
Date: November 16, 2022     By:  

/s/ Irene P. McCarthy

    Name:   Irene P. McCarthy
      Chief Executive Officer
Stealth BioTherapeutics (NASDAQ:MITO)
Historical Stock Chart
Von Mai 2024 bis Jun 2024 Click Here for more Stealth BioTherapeutics Charts.
Stealth BioTherapeutics (NASDAQ:MITO)
Historical Stock Chart
Von Jun 2023 bis Jun 2024 Click Here for more Stealth BioTherapeutics Charts.